A groundbreaking trial will investigate whether a specialist medical tampon could help identify the earliest indicators of ovarian cancer. The test searches for minuscule biological markers in vaginal fluid and has the potential to be a "complete game-changer" for the condition, which is typically diagnosed at a late stage. Around 250 women are being enrolled for the trial, called Violet and overseen by researchers in Southampton. Participants will include patients who have received an ovarian